The largest database of trusted experimental protocols

4 protocols using iomeprol

1

Dual-Source CT Angiography for Lung Perfusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two dual-source CT scanners (SOMATOM Definition Flash or SOMATOM Force; Siemens, Germany) were used to examine all patients. The non-ionic contrast media used were iopamidol (370 mgI/mL; Bayer Healthcare, Germany) or iomeprol (350 mgI/mL; Eisai, Japan). An automated power injector was used to administer 100 mL of non-ionic contrast medium at a flow rate of 22.2 mgI/kg/s and an additional 40-mL bolus of 0.9% saline solution at the same flow rate through a 22-gauge catheter.
The automatic bolus tracking method with a region of interest (ROI) placed on the pulmonary artery trunk, which triggered 250 Hounsfield units (HU), was used, and the CTPA scan of CTPA started 10 s after the trigger.
The following parameters were used in the SOMATOM Definition Flash: tube voltage, 140 and 100 kV; detector collimation, 2 × 64 mm × 0.6 mm; rotation time, 330 ms; and pitch, 0.55. The following parameters were used in the SOMATOM Force: tube voltage, 150 and 90 kV; detector collimation, 2 × 64 mm × 0.6 mm; rotation time, 280 ms; and pitch, 0.55. Lung iodine distribution (iodine map) and LPBV images were generated using a workstation (Syngo Acquisition Workplace; Siemens, Germany). LPBV images were created by the fusion of iodine maps and lung CTPA images.
+ Open protocol
+ Expand
2

Reagent Procurement for Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Penicillin/streptomycin, Dulbecco’s Modified Eagles Medium (DMEM), and DMEM/Ham’s F12 were purchased from Thermo Fisher Scientific Inc. (Kanagawa, Japan). Iomeprol (300 mgI/mL in saline) was purchased from Eisai Co., Ltd., Tokyo, Japan, and G418 was purchased from Merck KGaA, Darmstadt, Germany. Iomeprol contains 300 mg/mL of iodine; 612.4 mg/mL Iomeprol is equivalent to 300 mgI/mL of Iomeprol.
+ Open protocol
+ Expand
3

Whole-Body Contrast-Enhanced CT Scans

Check if the same lab product or an alternative is used in the 5 most similar protocols
All examinations were performed with the same 64-slice multi-detector CT scanner (Aquilion 64; Toshiba Medical Systems, Otawara, Japan). Images were acquired with a 1 mm slice thickness, a 0.5 sec rotation time, a beam pitch of 0.83, and 120 kVp of x-ray tube voltage. Automatic exposure control was used for dose reduction. CT scans were conducted after intravenous injection of 2 ml/kg of nonionic contrast medium (300 mg of iodine per milliliter: Iomeprol, Eisai, Tokyo, Japan; Iopamidol, Nihon Schering, Osaka, Japan) at a rate of 2.5 ml/sec in 10 patients. Scan areas were from chest to pelvis in eight patients, and from chest to upper abdomen in seven patients. All scans were reconstructed with a field of view of 350 mm in a 512×512 matrix (0.685×0.685 mm in-plane resolution), with a 1.0 mm slice thickness using a soft tissue kernel (FC13 of the Toshiba CT) to maintain a high signal-to-noise ratio (SNR).
+ Open protocol
+ Expand
4

128-DETECTOR ROW CT IMAGING PROTOCOL

Check if the same lab product or an alternative is used in the 5 most similar protocols
All CTs were performed using a 128-detector row computed tomography (CT) system (SOMATOM Definition Flash; Siemens; Erlangen, Germany). The following imaging parameters were applied: tube voltage, 120 kVp; tube current, 160 mAs; beam pitch, 0.6; resolution 0.68 × 0.68 × 5 mm. Contrast agent (iomeprol, Iomeron 350; Eisai, Tokyo, Japan; 100 mL) was administered from the superficial vein of the upper extremity using double-head power injector (injection rate, 4.5 mL/sec). The contrast agent was followed by normal saline (30 mL) at the same injection rate. Imaging slices from the skull base to the lower were acquired 40 s after contrast agent injection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!